Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tomoyuki Yamanoue"'
Autor:
Yoshikazu Yuki, Shiho Kurokawa, Kotomi Sugiura, Koji Kashima, Shinichi Maruyama, Tomoyuki Yamanoue, Ayaka Honma, Mio Mejima, Natsumi Takeyama, Masaharu Kuroda, Hiroko Kozuka-Hata, Masaaki Oyama, Takehiro Masumura, Rika Nakahashi-Ouchida, Kohtaro Fujihashi, Takashi Hiraizumi, Eiji Goto, Hiroshi Kiyono
Publikováno v:
Frontiers in Plant Science, Vol 15 (2024)
We previously established the selection-marker-free rice-based oral cholera vaccine (MucoRice-CTB) line 51A for human use by Agrobacterium-mediated co-transformation and conducted a double-blind, randomized, placebo-controlled phase I trial in Japan
Externí odkaz:
https://doaj.org/article/7b4a2074dd93404f8d74acfa66ff2b73
Autor:
Shingo Umemoto, Rika Nakahashi-Ouchida, Yoshikazu Yuki, Shiho Kurokawa, Tomonori Machita, Yohei Uchida, Hiromi Mori, Tomoyuki Yamanoue, Takehiko Shibata, Shin-ichi Sawada, Kazuya Ishige, Takashi Hirano, Kohtaro Fujihashi, Kazunari Akiyoshi, Yosuke Kurashima, Daisuke Tokuhara, Peter B Ernst, Masashi Suzuki, Hiroshi Kiyono
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-16 (2023)
Abstract Respiratory syncytial virus (RSV) is a leading cause of upper and lower respiratory tract infection, especially in children and the elderly. Various vaccines containing the major transmembrane surface proteins of RSV (proteins F and G) have
Externí odkaz:
https://doaj.org/article/27bafa5bb1384d08a0dc201789536623
Autor:
Rika Nakahashi-Ouchida, Hiromi Mori, Yoshikazu Yuki, Shingo Umemoto, Takashi Hirano, Yohei Uchida, Tomonori Machita, Tomoyuki Yamanoue, Shin-ichi Sawada, Masashi Suzuki, Kohtaro Fujihashi, Kazunari Akiyoshi, Yuichi Kurono, Hiroshi Kiyono
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Nontypeable Haemophilus influenzae (NTHi) strains form a major group of pathogenic bacteria that colonizes the nasopharynx and causes otitis media in young children. At present, there is no licensed vaccine for NTHi. Because NTHi colonizes the upper
Externí odkaz:
https://doaj.org/article/a589e942b7ea4e2991656a7fd55bc6f7
Autor:
Rika, Nakahashi-Ouchida, Hiromi, Mori, Yoshikazu, Yuki, Shingo, Umemoto, Takashi, Hirano, Yohei, Uchida, Tomonori, Machita, Tomoyuki, Yamanoue, Shin-Ichi, Sawada, Masashi, Suzuki, Kohtaro, Fujihashi, Kazunari, Akiyoshi, Yuichi, Kurono, Hiroshi, Kiyono
Publikováno v:
Frontiers in immunology. 13
Nontypeable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c55964e509de486bd70670f0c356d9a
https://pubmed.ncbi.nlm.nih.gov/35874779
https://pubmed.ncbi.nlm.nih.gov/35874779
Autor:
Yoshikazu Yuki, Masanori Nojima, Koji Kashima, Kotomi Sugiura, Shinichi Maruyama, Shiho Kurokawa, Tomoyuki Yamanoue, Rika Nakahashi-Ouchida, Hiroyuki Nakajima, Takashi Hiraizumi, Hitoshi Kohno, Eiji Goto, Kohtaro Fujihashi, Hiroshi Kiyono
Publikováno v:
Vaccine. 40(24)
MucoRice-CTB is a promising cold-chain-free oral cholera vaccine candidate. Here, we report a double-blind, randomized, placebo-controlled, phase I study conducted in the USA in which vaccination with the 6-g dose of MucoRice-CTB induced cross-reacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::923ce620dc6f23746fbc72243a12c4c0
https://pubmed.ncbi.nlm.nih.gov/35484039
https://pubmed.ncbi.nlm.nih.gov/35484039
Autor:
David E. Briles, Yoshikazu Yuki, Yohei Uchida, Tomonori Machita, Hiromi Mori, Tomoyuki Yamanoue, Reshmi Mukerji, Shiho Kurokawa, Kazunari Akiyoshi, Kotomi Sugiura, Ayaka Honma, Shin-ichi Sawada, Rika Nakahashi-Ouchida, Hiroshi Kiyono
Publikováno v:
Molecular pharmaceutics. 18(4)
We previously developed a safe and effective nasal vaccine delivery system using a self-assembled nanosized hydrogel (nanogel) made from a cationic cholesteryl pullulan. Here, we generated three pneumococcal surface protein A (PspA) fusion antigens a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d59d11dee0a86954c4518353e584e344
https://pubmed.ncbi.nlm.nih.gov/33621107
https://pubmed.ncbi.nlm.nih.gov/33621107